| Aug 7 |
Tyra Biosciences Reports Second Quarter 2024 Financial Results and Highlights
|
| Jul 23 |
Lots Of Bullish Signals, But No Revenue Or Earnings From Tyra Biosciences
|
| Jul 2 |
Tyra Biosciences Announces Preclinical Proof-of-Concept Results with TYRA-300 in Hypochondroplasia (HCH)
|
| Jun 23 |
Does This Valuation Of Tyra Biosciences, Inc. (NASDAQ:TYRA) Imply Investors Are Overpaying?
|
| Jun 7 |
Tyra Biosciences (TYRA) Upgraded to Buy: What Does It Mean for the Stock?
|
| Jun 7 |
Wall Street Analysts See a 27.27% Upside in Tyra Biosciences (TYRA): Can the Stock Really Move This High?
|
